Experimental Ebola Vaccine Trial’s Initial Results ‘Promising,’ WHO’s Chan Says Ahead Of Data Publication

Agence France-Presse: Ebola vaccine shows ‘promising’ results: WHO
“Preliminary results of tests on an Ebola vaccine to be published in British science magazine The Lancet later Friday have shown ‘promising’ results, World Health Organization Director-General Margaret Chan said…” (7/31).

Reuters: WHO’s Chan says initial results from Ebola vaccine trial ‘promising’
“… ‘If proven effective, this is going to be a game changer, and it will change the management of the current Ebola outbreak and future outbreaks,’ Chan told reporters at a news conference. Data from a trial of an Ebola vaccine known as VSV-EBOV developed by Merck and NewLink Genetics are expected to be published later on Friday” (Miles/Kelland, 7/31).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.